Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Adams

Showing results (141-150 of 143) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 143 results.
Journal of the National Cancer Institute|December 22, 2017
Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram ProjectKatrin M Sjoquist, Lindsay A Renfro, R John Simes, et al.
Eclinicalmedicine|June 24, 2026
Cediranib with weekly paclitaxel or olaparib versus weekly paclitaxel for advanced or recurrent endometrial cancer (COPELIA): a multicentre, open-label, randomised, phase 2 trial in the UKRobert D Morgan, Catharine Porter, Cong Zhou, et al.
Cancer Treatment Reviews|April 3, 2025
EORTC consensus recommendations on the optimal management of colorectal cancer liver metastasesGiacomo Bregni, Richard Adams, Reto Bale, et al.
Pageof 15

Showing results (141-150 of 143) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 143 results.
Journal of the National Cancer Institute|December 22, 2017
Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram ProjectKatrin M Sjoquist, Lindsay A Renfro, R John Simes, et al.
Eclinicalmedicine|June 24, 2026
Cediranib with weekly paclitaxel or olaparib versus weekly paclitaxel for advanced or recurrent endometrial cancer (COPELIA): a multicentre, open-label, randomised, phase 2 trial in the UKRobert D Morgan, Catharine Porter, Cong Zhou, et al.
Cancer Treatment Reviews|April 3, 2025
EORTC consensus recommendations on the optimal management of colorectal cancer liver metastasesGiacomo Bregni, Richard Adams, Reto Bale, et al.
Pageof 15